Related Experiment Videos
Cystourethroscopic findings before and after prostate brachytherapy
Summary
Cystourethroscopy findings during prostate brachytherapy show high variability and do not reliably predict postimplant urinary retention risk. Obstruction levels observed during the procedure are not strong indicators of retention.
Area of Science:
- Urology
- Oncology
- Medical Imaging
Background:
- Prostate brachytherapy is a common treatment for localized prostate cancer.
- Urinary retention is a potential complication following prostate brachytherapy.
- Predicting urinary retention risk is crucial for patient management.
Purpose of the Study:
- To evaluate the effectiveness of cystourethroscopy in predicting postimplant urinary retention after prostate brachytherapy.
- To determine if pre-implant or post-implant cystourethroscopic findings correlate with urinary retention.
Main Methods:
- Fifteen patients undergoing prostate brachytherapy (125I or 103Pd) were studied.
- Cystourethroscopy was performed before and after the brachytherapy implant procedure.
- Degree of urethral obstruction was assessed using a 3-point scale and photographic documentation.
Main Results:
- Pre-implant cystourethroscopy revealed a wide range of obstruction, from minimal to complete occlusion.
- No significant correlation was found between American Urologic Association (AUA) scores, prostate volume, and obstruction degree.
- While most patients experienced increased obstruction post-procedure, only one of six completely obstructed patients developed retention.
Conclusions:
- Variability in cystourethroscopy findings does not strongly influence the likelihood of postimplant urinary retention.
- Cystourethroscopy is not a reliable predictor for identifying patients at risk of urinary retention after prostate brachytherapy.